BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15050217)

  • 1. Controversies surrounding xanthine therapy.
    Millar D; Schmidt B
    Semin Neonatol; 2004 Jun; 9(3):239-44. PubMed ID: 15050217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B
    Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylxanthine treatment for apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD000140. PubMed ID: 21154343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine for apnea of prematurity.
    Coulter DM
    N Engl J Med; 2006 Aug; 355(9):958-9; author reply 959-60. PubMed ID: 16943412
    [No Abstract]   [Full Text] [Related]  

  • 7. Caffeine for apnea of prematurity.
    Hand IL; Noble LM
    N Engl J Med; 2006 Aug; 355(9):959; author reply 959-60. PubMed ID: 16948188
    [No Abstract]   [Full Text] [Related]  

  • 8. Caffeine versus theophylline for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine for apnea of prematurity.
    Bancalari E
    N Engl J Med; 2006 May; 354(20):2179-81. PubMed ID: 16707756
    [No Abstract]   [Full Text] [Related]  

  • 11. Early childhood developmental follow-up of infants with GMH/IVH: effect of methylxanthine therapy.
    Ment LR; Scott DT; Ehrenkranz RA; Duncan CC
    Am J Perinatol; 1985 Jul; 2(3):223-7. PubMed ID: 4015773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine for apnea of prematurity: a neonatal success story.
    Kreutzer K; Bassler D
    Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the caffeination of prematurity.
    Stevenson DK
    N Engl J Med; 2007 Nov; 357(19):1967-8. PubMed ID: 17989390
    [No Abstract]   [Full Text] [Related]  

  • 14. Question 1 Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Winckworth LC; Powell E
    Arch Dis Child; 2010 Sep; 95(9):757-9. PubMed ID: 20716677
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000140. PubMed ID: 10796304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Archimedes: Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
    Schmidt B; Roberts RS; Davis P; Doyle LW;
    Arch Dis Child; 2011 Aug; 96(8):784. PubMed ID: 21377992
    [No Abstract]   [Full Text] [Related]  

  • 17. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity.
    Al-Saif S; Alvaro R; Manfreda J; Kwiatkowski K; Cates D; Qurashi M; Rigatto H
    J Pediatr; 2008 Oct; 153(4):513-8. PubMed ID: 18534618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.